These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Inhibition of the Ubc9 E2 SUMO-conjugating enzyme-CRMP2 interaction decreases NaV1.7 currents and reverses experimental neuropathic pain. François-Moutal L; Dustrude ET; Wang Y; Brustovetsky T; Dorame A; Ju W; Moutal A; Perez-Miller S; Brustovetsky N; Gokhale V; Khanna M; Khanna R Pain; 2018 Oct; 159(10):2115-2127. PubMed ID: 29847471 [TBL] [Abstract][Full Text] [Related]
8. Spastin Interacts with CRMP2 to Regulate Neurite Outgrowth by Controlling Microtubule Dynamics through Phosphorylation Modifications. Li S; Zhang J; Zhang J; Li J; Cheng L; Chen L; Cha C; Guo G CNS Neurol Disord Drug Targets; 2021 Oct; 20(3):249-265. PubMed ID: 33109053 [TBL] [Abstract][Full Text] [Related]
9. Collapsin response mediator protein-2: an emerging pathologic feature and therapeutic target for neurodisease indications. Hensley K; Venkova K; Christov A; Gunning W; Park J Mol Neurobiol; 2011 Jun; 43(3):180-91. PubMed ID: 21271304 [TBL] [Abstract][Full Text] [Related]
10. CRMP2 protein SUMOylation modulates NaV1.7 channel trafficking. Dustrude ET; Wilson SM; Ju W; Xiao Y; Khanna R J Biol Chem; 2013 Aug; 288(34):24316-31. PubMed ID: 23836888 [TBL] [Abstract][Full Text] [Related]
11. Structural Insights into the Altering Function of CRMP2 by Phosphorylation. Sumi T; Imasaki T; Aoki M; Sakai N; Nitta E; Shirouzu M; Nitta R Cell Struct Funct; 2018; 43(1):15-23. PubMed ID: 29479005 [TBL] [Abstract][Full Text] [Related]
12. Probing the lithium-response pathway in hiPSCs implicates the phosphoregulatory set-point for a cytoskeletal modulator in bipolar pathogenesis. Tobe BTD; Crain AM; Winquist AM; Calabrese B; Makihara H; Zhao WN; Lalonde J; Nakamura H; Konopaske G; Sidor M; Pernia CD; Yamashita N; Wada M; Inoue Y; Nakamura F; Sheridan SD; Logan RW; Brandel M; Wu D; Hunsberger J; Dorsett L; Duerr C; Basa RCB; McCarthy MJ; Udeshi ND; Mertins P; Carr SA; Rouleau GA; Mastrangelo L; Li J; Gutierrez GJ; Brill LM; Venizelos N; Chen G; Nye JS; Manji H; Price JH; McClung CA; Akiskal HS; Alda M; Chuang DM; Coyle JT; Liu Y; Teng YD; Ohshima T; Mikoshiba K; Sidman RL; Halpain S; Haggarty SJ; Goshima Y; Snyder EY Proc Natl Acad Sci U S A; 2017 May; 114(22):E4462-E4471. PubMed ID: 28500272 [TBL] [Abstract][Full Text] [Related]
13. Hierarchical CRMP2 posttranslational modifications control NaV1.7 function. Dustrude ET; Moutal A; Yang X; Wang Y; Khanna M; Khanna R Proc Natl Acad Sci U S A; 2016 Dec; 113(52):E8443-E8452. PubMed ID: 27940916 [TBL] [Abstract][Full Text] [Related]
14. Localized role of CRMP1 and CRMP2 in neurite outgrowth and growth cone steering. Higurashi M; Iketani M; Takei K; Yamashita N; Aoki R; Kawahara N; Goshima Y Dev Neurobiol; 2012 Dec; 72(12):1528-40. PubMed ID: 22378692 [TBL] [Abstract][Full Text] [Related]
15. CRMP2: functional roles in neural development and therapeutic potential in neurological diseases. Ip JP; Fu AK; Ip NY Neuroscientist; 2014 Dec; 20(6):589-98. PubMed ID: 24402611 [TBL] [Abstract][Full Text] [Related]
16. A single structurally conserved SUMOylation site in CRMP2 controls NaV1.7 function. Dustrude ET; Perez-Miller S; François-Moutal L; Moutal A; Khanna M; Khanna R Channels (Austin); 2017 Jul; 11(4):316-328. PubMed ID: 28277940 [TBL] [Abstract][Full Text] [Related]
17. (S)-Lacosamide Binding to Collapsin Response Mediator Protein 2 (CRMP2) Regulates CaV2.2 Activity by Subverting Its Phosphorylation by Cdk5. Moutal A; François-Moutal L; Perez-Miller S; Cottier K; Chew LA; Yeon SK; Dai J; Park KD; Khanna M; Khanna R Mol Neurobiol; 2016 Apr; 53(3):1959-1976. PubMed ID: 25846820 [TBL] [Abstract][Full Text] [Related]
18. Coordinating Synaptic Signaling with CRMP2. Stratton H; Boinon L; Moutal A; Khanna R Int J Biochem Cell Biol; 2020 Jul; 124():105759. PubMed ID: 32437854 [TBL] [Abstract][Full Text] [Related]
19. Tau-tubulin kinase 1 and amyloid-β peptide induce phosphorylation of collapsin response mediator protein-2 and enhance neurite degeneration in Alzheimer disease mouse models. Ikezu S; Ingraham Dixie KL; Koro L; Watanabe T; Kaibuchi K; Ikezu T Acta Neuropathol Commun; 2020 Feb; 8(1):12. PubMed ID: 32019603 [TBL] [Abstract][Full Text] [Related]
20. Chemical shift perturbation mapping of the Ubc9-CRMP2 interface identifies a pocket in CRMP2 amenable for allosteric modulation of Nav1.7 channels. François-Moutal L; Scott DD; Perez-Miller S; Gokhale V; Khanna M; Khanna R Channels (Austin); 2018; 12(1):219-227. PubMed ID: 30081699 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]